PFRMAT FN
TARGET T0597
MODEL 1
Binding site: 36, 37, 38, 39, 40, 41, 42, 43, 44, 46, 57, 58, 59, 77, 90, 109, 110, 111, 112, 113, 114, 115, 116, 117, 120, 155, 158, 160, 161, 163, 164, 173, 174, 179, 180, 220, 223, 289, 290,
Comment: Model based on 3I60 - Ligand:19A_C_3(2OJG)[Kd=-4.04]; SO4_B_2(2OJG)[Kd=-0.56]; 33A_C_3(2OJI)[Kd=-3.61]; SO4_B_2(2OJI)[Kd=-0.56]; 82A_C_3(2OJJ)[Kd=-3.39]; SO4_B_2(2OJJ)[Kd=-1.14]; ADP_C_3(2B9F)[Kd=-3.14]; F29_B_2(1WZY)[Kd=-1.73]; FRR_A_2(2E14)[Kd=-4.82]; FRZ_B_2(1TVO)[Kd=-2.44]; HMY_A_3(3C9W)[Kd=-3.33]; SB4_B_2(3ERK)[Kd=-2.12]; OLO_C_3(4ERK)[Kd=-1.74]; SO4_B_2(4ERK)[Kd=-0.56]; ATP_A_3(1GOL)[Kd=-0.67]; ADP_C_3(2F9G)[Kd=-2.58]; ADP_D_4(2B9H)[Kd=-3.15]; ADP_D_4(2B9I)[Kd=-3.30]; ADP_D_4(2B9J)[Kd=-2.73]; ADP_A_7(2RIO)[Kd=-2.27]; AXX_G_7(2PZI)[Kd=-4.02]; ANP_D_4(1JNK)[Kd=-2.88]; ATP_E_5(1UA2)[Kd=-1.02]; ANP_C_3(1J1B)[Kd=-2.27]; EMO_A_4(3BQC)[Kd=-3.12]; RRC_A_5(1UNL)[Kd=-3.99]; 984_B_2(1PMN)[Kd=-3.41]; LIG_B_2(1JVP)[Kd=-4.24]; BEN_B_2(1LPU)[Kd=-1.72]; EDO_I_9(1HOW)[Kd=-0.71]; SO4_D_4(1HOW)[Kd=-0.56]; SO4_G_7(1HOW)[Kd=-0.56]; SO4_B_2(1IA8)[Kd=-0.56]; 
END
